WILTHERVA Trademark

Trademark Overview

On Thursday, July 8, 2021, a trademark application was filed for WILTHERVA with the United States Patent and Trademark Office. The USPTO has given the WILTHERVA trademark a serial number of 90817123. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, July 1, 2024. This trademark is owned by SLSG Limited LLC. The WILTHERVA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; cancer vaccines; pharmaceutical preparations for the treatment and prevention of cancer
wiltherva

General Information

Serial Number90817123
Word MarkWILTHERVA
Filing DateThursday, July 8, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, July 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and ServicesVaccines; cancer vaccines; pharmaceutical preparations for the treatment and prevention of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSLSG Limited LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDover, DE 19901
Party NameSLSG Limited LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDover, DE 19901

Trademark Events

Event DateEvent Description
Monday, July 12, 2021NEW APPLICATION ENTERED
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 28, 2022ASSIGNED TO EXAMINER
Monday, April 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 28, 2022SOU EXTENSION 1 FILED
Wednesday, December 28, 2022SOU EXTENSION 1 GRANTED
Sunday, June 18, 2023SOU EXTENSION 2 FILED
Friday, December 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 18, 2023SOU TEAS EXTENSION RECEIVED
Sunday, June 18, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 1, 2024SOU EXTENSION 4 FILED
Monday, July 1, 2024SOU EXTENSION 4 GRANTED
Monday, July 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 18, 2023SOU EXTENSION 3 FILED
Monday, December 18, 2023SOU EXTENSION 3 GRANTED

Related Keywords

wiltherva vaccines cancer prevention treatment pharmaceutical preparations